FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:2168-2170 December 26, 2002 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hermine, O. PubMed Citation

To the Editor: The report of Hermine et al. (July 11 issue)¹ provides important additional evidence as to the possible role of antiviral therapy for hepatitis C virus (HCV) infection in the treatment of patients with HCV-associated mixed cryoglobulinemia and lymphoma. They report regression of splenic lymphoma with villous lymphocytes and loss of HCV RNA in seven patients with mixed cryoglobulinemia and HCV infection after treatment with interferon. In five of these patients, molecular studies were performed, but none of them showed loss of the monoclonal immunoglobulin gene component.

In 1996, we reported complete remission of low-grade types of non-Hodgkin's . . . [Full Text of this Article]

This article has been cited by other articles:

• Saadoun, D., Landau, D. A., Calabrese, L. H., Cacoub, P. P. (2007). Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 46: 1234-1242 [Abstract] [Full Text]